leading researchers to believe that myasthenia gravis may be caused by varying underlying mechanisms for different people. Researchers at UC San Diego's School of Biological Sciences used a ...

Myasthenia gravis (MG) is a rare, chronic autoimmune disorder that disrupts the communication between nerves and muscles. It ...

"The newer medications that are coming out, and a lot of them are approved, are much more focused on the problem," explains ...

High rates of biologic naivety, limited switching, and ongoing unmet needs across the gMG landscape create opportunity for brand differentiation.EXTON, PA, May 15, 2025 (GLOBE NEWSWIRE) -- The ...

The Food and Drug Administration (FDA) has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older who are ...

Ultomiris (ravulizumab-cwvz) is a brand-name infusion prescribed for myasthenia gravis. This article covers topics such as side effects, dosage, and how Ultomiris works. Ultomiris is an ...

In the autoimmune disease myasthenia gravis, self-directed autoantibodies bind to the AChR, causing muscle weakness through several ways.

And anyone who suffers from myasthenia gravis, however mild it is, should be monitored, in particular with the eye muscle weakness or the eyelid weakness that occurs. It's important that any ...

Repository corticotrophin 80 Units/mL; gel for IM or SC inj. Purified Cortrophin Gel is the anterior pituitary hormone which stimulates the functioning adrenal cortex to produce and secrete ...

Welcome, everyone. I'm Dr. John Whyte, the Chief Medical Officer at WebMD. Today, I want to discuss myasthenia gravis. It's a rare autoimmune neuromuscular disease that causes weakness and fatigue ...

Johnson & Johnson won U.S. approval on April 30, 2025, of its new drug Imaavy for generalized myasthenia gravis. 37,530 people played the daily Crossword recently. Can you solve it faster than ...